| Literature DB >> 23555647 |
Timothy Y Liu1, Jason L Sanders, Fu-Chiang Tsui, Jeremy U Espino, Virginia M Dato, Joe Suyama.
Abstract
We studied the association between OTC pharmaceutical sales and volume of patients with influenza-like-illnesses (ILI) at an urgent care center over one year. OTC pharmaceutical sales explain 36% of the variance in the patient volume, and each standard deviation increase is associated with 4.7 more patient visits to the urgent care center (p<0.0001). Cross-correlation function analysis demonstrated that OTC pharmaceutical sales are significantly associated with patient volume during non-flu season (p<0.0001), but only the sales of cough and cold (p<0.0001) and thermometer (p<0.0001) categories were significant during flu season with a lag of two and one days, respectively. Our study is the first study to demonstrate and measure the relationship between OTC pharmaceutical sales and urgent care center patient volume, and presents strong evidence that OTC sales predict urgent care center patient volume year round.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23555647 PMCID: PMC3605458 DOI: 10.1371/journal.pone.0059273
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Selected OTC Pharmaceutical Categories from the National Retail Data Monitor.
| Categories | Used in analysis |
| Antidiarrheal | Not Selected |
| Antifever Pediatric | Selected |
| Antifever Adult | Selected |
| Bronchial Remedies | Not Selected |
| Chest Rubs | Not Selected |
| Cold Relief Adult Liquid | Not Selected |
| Cold Relief Adult Tablet | Not Selected |
| Cold Relief Pediatric Liquid | Not Selected |
| Cold Relief Pediatric Tablet | Not Selected |
| Cough Syrup Adult Liquid | Not Selected |
| Cough Adult Tablet | Not Selected |
| Cough Syrup Pediatric Liquid | Not Selected |
| Cough and Cold | Selected |
| Electrolytes Pediatric | Selected |
| Hydrocortisones | Not Selected |
| Nasal Product Internal | Not Selected |
| Thermometers | Selected |
| Throat Lozenges | Selected |
OTC, over-the-counter.
ICD-9 Code Set for the Selection of Patients with Influenza-Like-Illnesses.
| Syndromes | ICD-9 Codes |
| Pharyngitis | 462, 463, 034.0 |
| URI | 465.8, 465.9 |
| Laryngitis | 464.00, 464.4 |
| Sinusitis | 461, 461.9 |
| Cough | 786.2 |
| Viral Syndrome | 079.99 |
| Pneumonia | 486 |
| Otitis Media | 382.9 |
| Conjunctivitis | 372 |
| Bronchitis | 490, 466 |
| Flu | 487.8, 487.1 |
The documentation and coding system used at the Urgent Care system only included 486 as the diagnosis for all clinical pneumonia, as only clinical and radiographic evidence was available. No specific definitive testing was performed at the Urgent Care, and the only available ICD-9 code available for the provider to select at the time of disposition was 486 by default for any patient that qualified clinically for pneumonia.
Figure 1ILI Patient Volume vs. Total OTC Sales (7dMA).
Seven day moving average (7dMA) of OTC pharmaceutical sales and volume of patients with influenza-like-illness (ILI) patient volume at the UPMC Urgent Care from July 1, 2010 to July 31, 2011. Volume of patients with ILI is blue and on the left y-axis, and OTC pharmaceutical sales is red and on the right y-axis.
Figure 2ILI Patient Volume vs. Cough and Cold, Chest Rub, and Thermometer Sales Volume (7dMA).
Seven day moving average (7dMA) of sales volume of Cough and Cold medications (A), Chest Rubs (B), and Thermometers (C) in comparison with and volume of patients with influenza-like-illness (ILI) at the UPMC Urgent Care from July 1, 2010 to July 31, 2011. Volume of patients with ILI is blue and on the left y-axis, and the three different categories of OTC pharmaceutical sales are on the right y-axis.
Ordinary least square regression analysis of the association of OTC sales with urgent care ILI patient volume.
| Entire time period (July 1, 2010–July 31, 2011) | |||||
| Category | r2 | β | SD (OTCsales) | B × SD | P-value |
| Cough and Cold | 0.385 | 0.020 | 245.5 | 4.9 | <0.0001 |
| Chest Rubs | 0.366 | 0.591 | 8.1 | 4.8 | <0.0001 |
| Thermometers | 0.363 | 1.485 | 3.2 | 4.8 | <0.0001 |
| Electrolytes Pediatric | 0.269 | 0.952 | 4.3 | 4.1 | <0.0001 |
| Throat Lozenges | 0.183 | 0.105 | 32.1 | 3.4 | <0.0001 |
| Antifever Adult | 0.168 | 0.136 | 23.8 | 3.2 | <0.0001 |
| Antifever Pediatric | 0.120 | 0.568 | 4.8 | 2.7 | <0.0001 |
|
|
|
|
| 4.7 |
|
|
| |||||
|
|
|
|
|
|
|
| Cough and Cold | 0.797 | 0.014 | 253.6 | 3.6 | <0.0001 |
| Chest Rubs | 0.829 | 0.572 | 6.3 | 3.6 | <0.0001 |
| Thermometers | 0.323 | 1.314 | 1.7 | 2.3 | <0.0001 |
| Electrolytes Pediatric | 0.212 | 0.618 | 3.0 | 1.8 | <0.0001 |
| Throat Lozenges | 0.771 | 0.138 | 25.3 | 3.5 | <0.0001 |
| Antifever Adult | 0.465 | 0.248 | 11.0 | 2.7 | <0.0001 |
| Antifever Pediatric | 0.083 | 0.427 | 2.7 | 1.1 | 0.0003 |
|
|
|
|
|
|
|
|
| |||||
|
|
|
|
|
|
|
| Cough and Cold | 0.164 | 0.032 | 89.5 | 2.8 | <0.0001 |
| Chest Rubs | 0.003 | 0.071 | 5.2 | 0.4 | 0.56 |
| Thermometers | 0.485 | 1.540 | 3.2 | 4.9 | <0.0001 |
| Electrolytes Pediatric | 0.000 | 0.040 | 3.1 | 0.1 | 0.85 |
| Throat Lozenges | 0.009 | 0.044 | 14.9 | 0.7 | 0.3 |
| Antifever Adult | 0.007 | −0.042 | 13.7 | −0.6 | 0.37 |
| Antifever Pediatric | 0.000 | 0.019 | 3.8 | 0.1 | 0.91 |
|
|
|
|
| 2.3 |
|
|
| |||||
|
|
|
|
|
|
|
| Cough and Cold | 0.697 | 0.022 | 166.6 | 3.7 | <0.0001 |
| Chest Rubs | 0.662 | 1.394 | 2.6 | 3.6 | <0.0001 |
| Thermometers | 0.484 | 1.942 | 1.6 | 3.1 | <0.0001 |
| Electrolytes Pediatric | 0.492 | 1.279 | 2.4 | 3.1 | <0.0001 |
| Throat Lozenges | 0.787 | 0.185 | 21.0 | 3.9 | <0.0001 |
| Antifever Adult | 0.708 | 0.155 | 23.8 | 3.7 | <0.0001 |
| Antifever Pediatric | 0.529 | 1.389 | 2.3 | 3.2 | <0.0001 |
|
|
|
|
| 3.7 |
|
ILI, influenza like illness. OTC, over the counter medication. SD, standard deviation.
β represents the increase in the number of urgent care patients per unit increase in the sale of OTC medication.
β represents the increase in the number of urgent care patients per SD increase in the sale of OTC medication.
ARIMA analysis of the association of OTC sales with urgent care ILI patient volume.
| Entire time period (July 1, 2010–July 31, 2011) | |||
| Category | CCF (SE) | Lag | P-value <0.05 |
| Cough and Cold | 0.621 (0.050) | 0 | Y |
| Chest Rubs | 0.605 (0.050) | 0 | Y |
| Thermometers | 0.602 (0.050) | 0 | Y |
| Electrolytes Pediatric | 0.519 (0.050) | 0 | Y |
| Throat Lozenges | 0.428 (0.050) | 0 | Y |
| Antifever Adult | 0.410 (0.050) | 0 | Y |
| Antifever Pediatric | 0.347 (0.050) | 0 | Y |
|
|
|
|
|
|
| |||
|
|
|
|
|
| Cough and Cold | 0.898 (0.081) | 3 | Y |
| Chest Rubs | 0.911 (0.081) | 0 | Y |
| Thermometers | 0.698 (0.081) | 8 | Y |
| Electrolytes Pediatric | 0.547 (0.081) | 7 | Y |
| Throat Lozenges | 0.878 (0.081) | 0 | Y |
| Antifever Adult | 0.715 (0.081) | −4 | Y |
| Antifever Pediatric | 0.481 (0.081) | 15 | Y |
|
|
|
|
|
|
| |||
|
|
|
|
|
| Cough and Cold | 0.412 (0.091) | 2 | Y |
| Chest Rubs | −0.517 (0.091) | −15 | Y |
| Thermometers | 0.697 (0.091) | 1 | Y |
| Electrolytes Pediatric | 0.293 (0.091) | 9 | Y |
| Throat Lozenges | 0.568 (0.091) | −15 | Y |
| Antifever Adult | 0.135 (0.091) | 14 | N |
| Antifever Pediatric | 0.323 (0.091) | 15 | Y |
|
|
|
|
|
|
| |||
|
|
|
|
|
| Cough and Cold | 0.835 (0.092) | 0 | Y |
| Chest Rubs | 0.813 (0.092) | 0 | Y |
| Thermometers | 0.696 (0.092) | 0 | Y |
| Electrolytes Pediatric | 0.701 (0.092) | 0 | Y |
| Throat Lozenges | 0.887 (0.092) | 0 | Y |
| Antifever Adult | 0.841 (0.092) | 0 | Y |
| Antifever Pediatric | 0.727 (0.092) | 1 | Y |
|
|
|
|
|
ARIMA, autoregressive integrated moving average. CCF, cross correlation function. ILI, influenza like illness. OTC, over the counter medication. SE, standard error.
For analysis of the entire time period the lag was fixed to 0. For analysis of sub-periods the lag was limited to within 15 days. A positive lag indicates sale of OTC medication is correlated with future urgent care patient volume. A negative lag indicates sale of OTC medication is correlated with past urgent care patient volume.
P-value <0.05 was determined if: CCF - (1.96×SE) >0.